Organization of pharmaceutical consulting during the release of combined medicines by prescription
- Authors: Porseva N.Y.1, Rostova N.B.1, Soloninina A.V.1, Foteeva A.V.1
-
Affiliations:
- FSBEI HE «Perm State Pharmaсeutiсal Aсademy» of the Health Ministry of Russia
- Issue: Vol 73, No 3 (2024)
- Pages: 50-56
- Section: Organization and economy
- URL: https://journals.eco-vector.com/0367-3014/article/view/633227
- DOI: https://doi.org/10.29296/25419218-2024-03-08
- ID: 633227
Cite item
Open Access
Access granted
Abstract
Introduction. In order to realize the increasing role of a pharmaceutical specialist in ensuring the quality of professional activity, promoting a healthy lifestyle and rational use of medicines through pharmaceutical counseling, it is necessary to justify standardized approaches to the implementation of individual groups of drugs, taking into account the conditions of their release from pharmacy organizations, the characteristics of their pharmacological effects, potential non-medical use and other factors.
Objective: Substantiation of the methodological approach to the organization of pharmaceutical consulting during the release of prescription drugs (on the example of combined drugs containing small amounts of narcotic drugs, psychotropic substances and their precursors).
Material and methods: Review and analysis of modern research, regulatory documents in the Russian Federation and recommendations of the World Health Organization on pharmaceutical consulting, aspects of rational choice, prescription and use of medicines, their release from pharmacy organizations, instructions for medical use, publications from the databases of RSCI, PubMed, Scopus, etc. A content analysis of official information sources was carried out about medicines.
Results. The results of the substantiation of the methodological approach to the organization of pharmaceutical counseling for the release of prescription combined drugs containing small amounts of narcotic drugs, psychotropic substances and their precursors, taking into account the current regulations for their circulation; facts of abuse and drug addiction; assortment and its systematization from the perspective of the release from pharmacy organizations; restrictions on use in childhood.
Conclusion. The proposed approach can be used as a basis for the development of information and organizational technologies for optimizing the provision of medicines to the population and pharmaceutical counseling of patients with prescription drugs (standard operating procedures, consulting algorithms, drug databases, etc.), the implementation of which in practice will contribute to improving the quality of pharmaceutical services.
Full Text
About the authors
Natalia Yuryevna Porseva
FSBEI HE «Perm State Pharmaсeutiсal Aсademy» of the Health Ministry of Russia
Author for correspondence.
Email: porseva-nu@pfa.ru
ORCID iD: 0000-0002-3396-1567
PhD in Pharmaceutical Sciences, Associate Professor at the Department of Pharmacy Management and Economics
Russian Federation, PermNatalya Borisovna Rostova
FSBEI HE «Perm State Pharmaсeutiсal Aсademy» of the Health Ministry of Russia
Email: N-Rostova@mail.ru
ORCID iD: 0000-0001-5579-394X
Doctor of Pharmaceutical Sciences, Associate Professor, Professor at the Department of Pharmacy Management and Economics
Russian Federation, PermAnna Vladimirovna Soloninina
FSBEI HE «Perm State Pharmaсeutiсal Aсademy» of the Health Ministry of Russia
Email: soloninina@mail.ru
ORCID iD: 0000-0002-2745-7698
Doctor of Pharmaceutical Sciences, Professor, Head of the Department of Management and Economics of Pharmacy
Russian Federation, PermAlexandra Valeryevna Foteeva
FSBEI HE «Perm State Pharmaсeutiсal Aсademy» of the Health Ministry of Russia
Email: a.foteeva@parmaclinical.ru
ORCID iD: 0000-0002-3752-7848
PhD in Medical Sciences, Assistant at the Department of Pharmacy Management and Economics
Russian Federation, PermReferences
- Sobczak L., Goryński K. Pharmacological Aspects of Over-the-Counter Opioid Drugs Misuse. Molecules. 2020; 25 (17): 3905. doi: 10.3390/molecules25173905.
- Miuli A., Stigliano G., Lalli A., Coladonato M., D'Angelo L., Esposito F. "Purple Drank" (Codeine and Promethazine Cough Syrup): A Systematic Review of a Social Phenomenon with Medical Implications. J. Psychoactive Drugs. 2020; 52 (5): 453–62. doi: 10.1080/02791072.2020.1797250.
- Chiappini S., Schifano F., Corkery J. M., Guirguis A. Beyond the purple drank: Study of promethazine abuse according to the european medicines agency (EMA) adverse drug reactions (ADR) reports. J. Psychopharmacol. 2021; 35 (6): 681–92. doi: 10.1177/0269881120959615.
- Algarni M., Jalal Z., Hadi M. A., Alghamdi S. Community pharmacists' views and experiences toward over-the-counter medicines misuse and abuse in Saudi Arabia: A qualitative study. Front Pharmacol. 2022; 13: 997342. doi: 10.3389/fphar.2022.997342.
- Zaremba M., Serafin P., Kleczkowska P. Antipsychotic Drugs Efficacy in Dextromethorphan-Induced Psychosis. Biomedicines. 2023; 11 (1): 123. doi: 10.3390/biomedicines11010123.
- Martinak B., Bolis R. A., Black J. R., Fargason R. E., Birur B. Dextromethorphan in Cough Syrup: The Poor Man's Psychosis. Psychopharmacol Bull. 2017; 47 (4): 59–63.
- Suchecka D., Kucharska-Mazur J., Groszewska K., Mak M., Samochowiec J., Samochowiec A. Analysis of the phenomenon of over-the-counter drug abuse and not controlled herbs trade by Polish adolescents. Part I Med Pr. 2017; 68 (3): 413–22. doi: 10.13075/mp.5893.00245.
- Порсева Н.Ю., Солонинина А.В., Дворская О.Н. Изучение информированности фармацевтических работников по вопросам злоупотребления лекарственными препаратами. Фармация и фармакология. 2020; 8 (6): 456–64. doi: 10.19163/2307-9266-2020-8-6-456-464. [Porseva N.Yu., Soloninina A.V., Dvorskaya O.N. Study of pharmaceutical specialists’ information awareness on the matters of drug abuse. Farmaciya i farmakologiya. 2020; 8 (6): 456–64. doi: 10.19163/2307-9266-2020-8-6-456-464 (in Russian)].
- Государственный реестр лекарственных средств. [Электронное издание]. Режим доступа: https://grls.minzdrav.gov.ru/ [Дата обращения 11 октября, 2023]. [State Register of Medicines. [Electronic edition]. Access mode: https://grls.minzdrav.gov.ru/ [Accessed 11 October, 2023] (in Russian)].
- Единый реестр зарегистрированных лекарственных средств Евразийского экономического союза. [Электронное издание]. Режим доступа: https://portal.eaeunion.org/sites/commonprocesses/ru-ru/Pages/DrugRegistrationDetails.aspx [Дата обращения 11 Октября, 2023]. [Unified Register of Registered Medicines of the Eurasian Economic Union. [Electronic edition]. Access mode: https://portal.eaeunion. org/sites/commonprocesses/ru-ru/Pages/DrugRegistrationDetails.aspx [Accessed 11 October, 2023] (in Russian)].
- Promoting rational use of medicineshttps. [Electronic edition]. Access mode: https://www.who.int/activities/promoting-rational-use-of-medicines [Accessed 15 October, 2023].
- Ростова Н.Б. Международные рекомендации и национальные перспективы рационального использования лекарств для решения вопросов лекарственного обеспечения населения. Российский медицинский журнал. 2015; 21 (2): 40–5. [Rostova N.B. International recommendations and national prospects for the rational use of medicines to address issues of drug provision of the population. Rossijskij medicinskij zhurnal. 2015; 21 (2): 40–5 (in Russian)].
Supplementary files
